Objectives: To study the relationship between serum inhibin B and sex steroid concentrations and pituitary FSH responsiveness to GnRH in boys in early puberty, and to examine serum inhibin B levels in prepubertal boys with different timing of the onset of gonadotropin deficiency (GD). Design: Twenty-five boys with constitutional delay of puberty (CDP; 20 in Tanner stage G2 and 5 in G3; age range, 13.5-16.8 years) and eight prepubertal boys (G1P1) with GD (age range, 10.0-13.2 years) were clinically examined, and serum inhibin B, testosterone and estradiol concentrations were measured from sera obtained immediately before the administration of GnRH (Relefact; 3.5 mg/kg, maximum 100 mg i.v.). Thereafter, FSH levels were measured at 30 min intervals up to 90 min. Results: In the boys with CDP, basal inhibin B and FSH levels did not correlate. However, inhibin B and GnRH-stimulated FSH concentrations (r S ¼ ¹0.43 to ¹0.45, n ¼ 25, P < 0.05) and the difference between basal and peak serum FSH levels were inversely related (r S ¼ ¹0.63, n ¼ 25, P < 0.005). This relationship remained significant in boys at stage G2 (r S ¼ ¹0.66, n ¼ 20, P < 0.005). Basal testosterone concentrations and GnRH-induced FSH levels did not correlate. Estradiol levels were too low (64% of the boys had estradiol levels below the assay sensitivity) to allow correlation analysis. The boys with GD had low inhibin B concentrations (range, <15.6-53 pg/ml); the lowest levels were observed in boys with presumably congenital onset of the disease. Serum inhibin B levels and testis volumes correlated positively (r S ¼ 0.70, n ¼ 8, P ¼ 0.07). Conclusions: These results suggest that, in boys, the reciprocal regulation between inhibin B and FSH is in operation before mid-puberty. Moreover, autonomous inhibin B secretion by the prepubertal human testis is likely to reflect the number of Sertoli cells.
Introduction
Inhibin B, a glycoprotein hormone with two dissimilar subunits (a/bB), has been suggested to be the endocrinologically most important form of inhibin in men. In adults (1) and prepubertal boys (2), inhibin B is produced by Sertoli cells in response to folliclestimulating hormone (FSH) . Inhibin B appears to reciprocally inhibit FSH secretion, since in healthy men, men with various testicular disorders and in gonadotropin-deficient men during their gonadotropinreleasing hormone (GnRH) treatment, serum inhibin B and FSH levels correlate negatively (3-6). In addition, chemotherapy given to treat hematological malignancies and testicular irradiation given to treat germ cell cancer both suppress inhibin B secretion with a concomitant increase in circulating FSH levels (7, 8) . During puberty, basal inhibin B and FSH levels correlate negatively in boys at Tanner stage G3 or G4, suggesting the establishment of a feedback regulation loop at this stage of development (9, 10) . However, prepubertaland early pubertal-aged boys with primary hypogonadism have higher basal (11) (12) (13) and GnRH-induced (14) FSH concentrations than healthy boys of similar age, suggesting that the Sertoli cells regulate FSH secretion earlier.
Gonadotropin drive to the testis is undoubtedly the most important factor stimulating inhibin B secretion; serum levels increase during the postnatal activation of the hypothalamo-pituitary-testicular axis (15) , subside during the juvenile hiatus of gonadotropin secretion, rise in early puberty (9, 10) , and slowly decrease towards senescence (16) . On the other hand, Sertoli cells appear to be capable of autonomous inhibin B production. For example, testes of men with gonadotropin deficiency (GD) produce inhibin B (5, 6) , and, in boys, the postnatal secretion of inhibin B is sustained up to 18 months of age (15) . However, the factors affecting the autonomous inhibin B secretion are largely unknown.
In the present study, we examined the relationship between basal serum inhibin B concentration and GnRH-induced FSH responses in boys with constitutional delay of puberty (CDP). In addition, to investigate physiological correlates of autonomous inhibin B secretion, we examined eight prepubertal boys with different timing of the onset of GD.
Subjects and methods

Subjects
Twenty-five boys with CDP (mean age 15.3 years; range, 13.5-16.8 years) were enrolled. These boys had presented with delayed onset and progression of puberty (Tanner genital or pubic hair stage observed at an age equal to or older than the mean þ2 S.D. for healthy Finnish boys (17) or a testicular volume <4 ml at or after 13.5 years of age). The boys were short for their chronological ages (range of height S.D. score ¹1.1 to ¹3.2). One boy had asthma and another had a history of cleft lip and palate. None of the boys had received previous androgen treatment and none had clinical or laboratory evidence of any disease that could have accounted for their delayed puberty; instead, 68% had a history of delayed puberty in the family. Twenty boys were at Tanner stage G2 and 5 had detectable increases in the size of the penis (stage G3). The length and width of both testes were measured with a ruler, the volume of each testis was calculated using the formula length × width 2 × 0.52 (18) , and converted to milliliters. The mean volume of the testes in each boy ranged between 1.8 and 16.6 ml (median 5.3 ml). Bone age was determined from X-rays of the left hand by the same investigator (T R) using the radius, ulna and short bones (RUS) method (19) . In each boy, bone age was delayed (mean 12.9 years; range, 10.1-15.1 years). Six of the boys have been followed up for 12 months, and 18 boys for five months; during this time, puberty has progressed in each subject.
The second group consisted of eight prepubertal boys with GD. The diagnoses were based on clinical histories, prepubertal genitalia, low basal gonadotropin and sex steroid levels, and subnormal gonadotropin responses to GnRH (Table 1) . Three boys had clinical histories suggesting congenital onset of the disease (subjects 2, 5 and 8). None of the boys had received previous androgen or gonadotropin treatment. Other pituitary hormone deficiencies were adequately substituted. Clinical information, serum inhibin B (measured in a different laboratory), luteinizing hormone (LH) and FSH levels of three boys (subjects 3, 6 and 7; Table 1 ) have been published previously (2).
Serum inhibin B and sex steroid concentrations (testosterone and estradiol in boys with CDP, and testosterone in boys with GD) were measured from samples obtained immediately before (0 min) the administration of GnRH (Relefact, Hoechst, Frankfurt am Main, Germany; 3.5 mg/kg, maximum 100 mg i.v. as a rapid bolus); in subject 1 (Table 1) , serum inhibin B and testosterone levels were measured 3 months after the GnRH test. Serum FSH levels were measured from samples obtained 0 (before), 30, 60 and 90 min after the administration of GnRH. The corresponding time points for LH measurements were 0 (before), 20, 30 and 60 min. The GnRH test was performed between 0830 and 1500 h. In two prepubertal boys with GD (subjects 1 and 2; Table 1 ), serum FSH and LH levels were measured 0 (before), 20 and 70 min after the administration of GnRH. All blood samples were allowed to clot, after which the serum was separated by centrifugation. The sera were stored at ¹20 ЊC until required for analyses. Boys with CDP had higher GnRH-induced LH peaks (range, 2.6-30 IU/l) than those with GD (Table 1) .
The study protocol was accepted by the ethical committee of the Hospital for Children and Adolescents, University of Helsinki. Informed consent was obtained from the boys and their parents.
Assays
Gonadotropins and inhibin B Serum FSH and LH levels were measured with time-resolved ultrasensitive fluoroimmunometric assays (Wallac, Turku, Finland) as described previously (11) . The FSH standards were calibrated against the 2nd IRP of pituitary FSH/LH (78/549). The sensitivity of the FSH assay was 0.05 IU/l, as defined by a mean þ2 S.D. of multiple (singleton) zerosample measurements. The samples were also analyzed in singletons. For FSH, the within-and between-plate coefficients of variation (CVs) were less than 6%. The corresponding CVs for LH were less than 7%. We used a commercially available kit (Serotec, Oxford, Oxon, UK) to measure serum inhibin B levels. According to the manufacturer, sensitivity of the assay was 15.6 pg/ml. The standard provided was inhibin extracted from human follicular fluid. At a mean concentration of 115 pg/ml, calculated from the repeated measurement of the same sample, the within-assay CV was less than 5%. The between-assay CV, determined from 11 consecutive assay runs, was less than 7%.
Sex steroids Serum testosterone levels were measured with an RIA kit (Orion Diagnostica, Espoo, Finland). According to the manufacturer, the assay has a sensitivity of 0.1 nmol/l, and crossreacts minimally with other steroid hormones. The within-and between-assay CVs were less than 5 and 7% respectively. Serum estradiol concentrations were measured with an RIA kit (DiaSorin, Vercelli, Italy). The assay sensitivity, determined as a mean þ2 S.D. of multiple zero samples, was 24 pmol/l. All samples were analyzed in a single assay run; the within-assay CV was 15%. 
Statistical analyses
Spearman rank correlation was used to investigate the relationships between serum hormone levels and other parameters of puberty. Estradiol levels were not included in the analyses, because 64% of boys with CDP had concentrations below the assay sensitivity. Serum inhibin B levels within the group of boys with GD were compared using the Mann-Whitney U-test. Values are expressed as median (range). Values of P less than 0.05 were accepted as indicating statistical significance.
Results
In the 25 boys with CDP, the basal serum hormone concentrations were distributed as follows: inhibin B, median 179 pg/ml (range, 86-276 pg/ml); FSH, 2.1 IU/l (0.7-6.8 IU/l); LH, 1.8 IU/l (0.1-5.0 IU/l); testosterone, 3.8 nmol/l (0.5-17.8 nmol/l). In 16 boys, serum estradiol levels were below the assay detection limit; the median of the concentrations above the limit was 48 nmol/l (27-185 nmol/l). Serum inhibin B levels correlated with circulating testosterone concentrations (r S ¼ 0.42, n ¼ 25, P < 0.05), but not with chronological or bone ages and not with basal serum gonadotropin concentrations.
In each boy with CDP, the highest FSH level was observed 60 min after the administration of GnRH. Serum inhibin B levels correlated weakly with GnRHinduced FSH concentrations (r S ¼ ¹ 0.43 to ¹0.45, n ¼ 25, P < 0.05, Fig. 1A ), and strongly with the difference between basal and peak serum FSH levels (DS-FSH; r S ¼ ¹ 0.63, n ¼ 25, P < 0.005, Fig. 1B) . DS-FSH ranged from 0.9 to 4.5 IU/l. No inverse relationships were observed between circulating testosterone and GnRHstimulated FSH concentrations. The inverse relationship between inhibin B and DS-FSH remained statistically significant, even though only the boys at Tanner stage G2 were included in the correlation analysis (r S ¼ ¹ 0.66, n ¼ 20, P < 0.005).
Clinical parameters of puberty together with serum inhibin B, gonadotropin, and testosterone levels in boys with GD are presented in Table 1 . Subjects 2, 5 and 8 had lower inhibin B levels than the other five boys with GD (P < 0.05); in these boys, inhibin B concentrations were below the assay sensitivity. Boys with GD had a combination of low inhibin B levels and minimal GnRH-induced FSH concentrations (data shown in Table 1 ). In both subgroups, serum inhibin B concentrations and testis volumes correlated positively (r S ¼ 0.49, n ¼ 25, P < 0.05 in boys with CDP; r S ¼ 0.70, n ¼ 8, P ¼ 0.07 in boys with GD; Fig. 2 ).
Discussion
Several previous findings suggest that the testes regulate FSH secretion before mid-puberty. In boys at early puberty, for example, serum LH levels increase rapidly, whereas the corresponding rise in FSH levels is much smaller (12, (20) (21) (22) . At the transition from pre-to peripuberty, FSH responses to exogenous GnRH may even show a decreasing trend (23) . Direct evidence that inhibin B would mediate these changes is lacking. This is suggested, however, by the findings that inhibin B secretion increases in early puberty (9, 10) and, during short-term GnRH treatment of gonadotropindeficient men, serum inhibin B and FSH levels correlate negatively (6) . In boys in early puberty, we found an inverse relationship between serum inhibin B levels and GnRH-induced FSH concentrations. This finding is in contrast to the results of previous reports (9, 10) , and suggests that the feedback loop between inhibin B and FSH is operative already before mid-or late puberty. Parenthetically, no relationship between serum inhibin B levels and chronological or bone ages was observed. This was expected, since serum inhibin B concentrations reach adult levels already in boys at G2 (9), whereas bone age progresses until the end of somatic growth.
How are these findings related to Sertoli cell physiology? Before adulthood, Sertoli cells are immature and capable of dividing (24) . As suggested by rat (25, 26) and non-human primate models (27) , and clinical observations in humans (2, [28] [29] [30] , the number of Sertoli cells is likely to be FSH-dependent.
The prepubertal testis appears to lack, however, an intrinsic mechanism controlling this phenomenon, as exemplified by macro-orchidism in a prepubertal boy with an idiopathic elevation in serum FSH level (31) . Thus, it is tempting to hypothesize that the inverse relationship between inhibin B and FSH in boys in early puberty reflects the endocrine control of Sertoli cell proliferation. On the other hand, as judged from the circulating testosterone concentrations, testicular volumes and serum inhibin B levels, some of the boys with CDP have probably had spermarche (32) . In these boys, the relationship between inhibin B and FSH probably reflects the regulation of spermatogenesis.
Prepubertal boys with GD had low basal and GnRHinduced gonadotropin concentrations in combination with low inhibin B levels (below the reference range of our laboratory for healthy boys of similar age). The lowest inhibin B levels were observed in boys with congenital onset of the disease: two boys with GD had undervirilized genitalia suggesting GD in utero, and one boy had had a craniopharyngioma resected immediately after birth, resulting in a defective postnatal activation of the hypothalamo-pituitary-gonadal axis. These developmental disturbances probably impaired Sertoli cell proliferation, resulting in nondetectable serum inhibin B levels later in prepuberty. For example, in the rat, neonatal reduction of Sertoli cell number suppresses inhibin B production later in life (33) , and men with prepubertal onset of GD have lower inhibin B levels than those with histories of endogenous pubertal maturation (5) . Moreover, in prepubertal boys, inhibin B has been suggested to be produced exclusively by Sertoli cells (34) , the number of which correlates with the length of seminiferous tubules (35) . Subject 3 had the highest inhibin B concentration and the largest testis size, and for subject 5 the findings were opposite. On the basis of these findings, we suggest that in boys, similar to the previous suggestion for non-human primates (36) , the amount of inhibin B autonomously produced by the prepubertal testis reflects the number of Sertoli cells.
In conclusion, we found that in boys in early puberty, circulating inhibin B and GnRH-induced increases in serum FSH concentrations correlated negatively, suggesting feedback regulation between these hormones before mid-puberty. Moreover, we investigated inhibin B levels in eight prepubertal boys with GD. The findings suggest that the autonomous inhibin B production by the prepubertal human testis reflects the number of Sertoli cells. Twenty boys were at stage G2, and five at G3. Inset: (ᓄ) relationship between testis volumes and S-inhibin B levels in eight prepubertal boys with GD (r S ¼ 0.70, n ¼ 8, P ¼ 0.07).
